Celsus Therapeutics Plc. (CLTX) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 25 transactions totaling $856.7K, demonstrating a bullish sentiment with $856.7K in net insider flow. The most recent transaction on Jan 8, 2015 involved a transaction of 152,000 shares valued at $3.0K.
No significant insider buying has been recorded for CLTX in the recent period.
No significant insider selling has been recorded for CLTX in the recent period.
Based on recent SEC filings, insider sentiment for CLTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $856.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Celsus Therapeutics Plc. (CLTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CLTX stock, having executed 25 transactions in the past 90 days. The most active insider is Management, Llc Sabby (Executive), who has made 15 transactions totaling $666.0K.
Get notified when executives and directors at CLTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 8, 2015 | S. Cohen Mark | Executive | Exercise | 152,000 | $0.02 | $3.0K | |
| Jan 8, 2015 | S. Cohen Mark | Executive | Exercise | 50,700 | $0.02 | $1.0K | |
| Apr 15, 2014 | Volatility Master Fund, Ltd. Sabby Healthcare | Executive | Purchase | 17,100 | $5.00 | $85.5K | |
| Apr 14, 2014 | Volatility Master Fund, Ltd. Sabby Healthcare | Executive | Purchase | 3,000 | $5.21 | $15.6K | |
| Apr 11, 2014 | Mintz Hal | Executive | Purchase | 100 | $5.15 | $515 | |
| Apr 10, 2014 | Mintz Hal | Executive | Purchase | 1,400 | $5.25 | $7.3K | |
| Apr 9, 2014 | Mintz Hal | Executive | Purchase | 1,075 | $5.51 | $5.9K | |
| Apr 8, 2014 | Llc Sabby Management, | Executive | Purchase | 35,500 | $5.36 | $190.3K | |
| Apr 7, 2014 | Llc Sabby Management, | Executive | Purchase | 16,900 | $5.64 | $95.3K | |
| Apr 7, 2014 | Llc Sabby Management, | Executive | Purchase | 3,754 | $6.00 | $22.5K | |
| Apr 4, 2014 | Llc Sabby Management, | Executive | Purchase | 11,250 | $6.08 | $68.4K | |
| Apr 4, 2014 | Llc Sabby Management, | Executive | Purchase | 1,000 | $6.00 | $6.0K | |
| Apr 2, 2014 | Llc Sabby Management, | Executive | Purchase | 2,500 | $6.15 | $15.4K | |
| Apr 1, 2014 | Llc Sabby Management, | Executive | Purchase | 7,375 | $6.08 | $44.8K | |
| Apr 1, 2014 | Llc Sabby Management, | Executive | Purchase | 7,496 | $6.12 | $45.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 23 | $856.7K | 99.5% |
Exercise (Options)(X) | 2 | $4.1K | 0.5% |
Insiders at Celsus Therapeutics Plc. are accumulating shares at an accelerated pace. With 4 insiders making 25 transactions totaling $856.7K in purchases versus $0 in sales, the net buying activity of $856.7K signals strong executive confidence. Management, Llc Sabby (Executive) leads the buying activity with $666.0K in transactions across all time.